Skip to main content

Table 1 Correlation of miR-924 with clinicopathological features of patients with non-small cell lung cancer

From: MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway

miR-924 expression
Variable Total (n = 79) High (n = 34) Low (n = 45) P value
Gender     1.012
 Male 62 26 36  
 Female 17 8 9  
Age (year)     0.589
 < 60 45 13 32  
 ≥ 60 34 21 13  
Smoking history     0.485
 Yes 51 24 27  
 No 28 10 18  
Tumor size (cm)     0.063
 < 4 28 17 11  
 ≥ 4 51 17 34  
TNM stage     0.003
 I + II 66 30 36  
 III + IV 13 4 9  
Lymphatic metastasis     0.016
 Yes 28 7 21  
 No 51 27 24  
Pathological type     0.886
 Adenocarcinoma 36 15 21  
 Squamous carcinoma 43 19 24  
  1. The italic values indicates the P values which are less than 0.05